The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program
2011

Summary of the 2010 Primer on Tumor Immunology and Biological Therapy of Cancer

publication Evidence: moderate

Author Information

Author(s): James M. Balwit, Patrick Hwu, Walter J. Urba, Francesco M. Marincola

Conclusion

The Primer provided a comprehensive overview of tumor immunology and biological therapy, highlighting the importance of understanding immune responses to improve cancer treatment outcomes.

Supporting Evidence

  • The Primer included presentations on various topics such as innate immunity, adaptive immunity, and the role of dendritic cells in cancer treatment.
  • Therapies discussed included cancer vaccines and adoptive T cell therapy.
  • Research highlighted the importance of understanding the tumor microenvironment in developing effective immunotherapies.

Takeaway

This study is about a meeting where scientists talked about how our immune system can help fight cancer and what new treatments might work better.

Methodology

The report summarizes presentations from the 2010 Primer on Tumor Immunology and Biological Therapy of Cancer, focusing on various aspects of tumor immunology and treatment strategies.

Participant Demographics

The target audience included basic and clinical investigators from academia, industry, and regulatory agencies, as well as clinicians, post-doctoral fellows, students, and allied health professionals.

Digital Object Identifier (DOI)

10.1186/1479-5876-9-18

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication